Credit Agricole S A Nektar Therapeutics Transaction History

Credit Agricole S A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $267,085 - $384,995	-20,435 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$16.52 - $20.4 $52,864 - $65,279	3,200 Added 18.57%	20,435 $351,000
Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $243,349 - $374,134	14,695 Added 578.54%	17,235 $345,000
Q4 2020 Feb 12, 2021	BUY	$15.77 - $19.03 $23,655 - $28,545	1,500 Added 144.23%	2,540 $43,000
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $17,534 - $24,377	1,040 New	1,040 $24,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.